NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

Session ID: 2025-07-05:b4c0b442466a8b7cd5525a4f Player Element ID: vjs_video_3 ...

Going into the timeline of BioOrbit’s ambitions, King explained: “Our first step is to develop our proof-of-concept manufacturing line, which is flying this summer to the International Space Station ...

If you’re interested in learning more about clinical trials, the first step is to talk to your cancer care team. [2] Chances are, it’s already on their minds.

Aria Trivedi is a biology major with a minor in biotechnology, and she is a 2024-25 health care ethics intern at the Markkula Center for Applied Ethics at Santa Clara University. Views are her own.

Getting involved in research during medical college may feel intimidating at first, but it doesn’t have to be. Start small—assist a senior, join a faculty-led study, or attend a research workshop.

Novo Nordisk is progressing both subcutaneous and oral versions of amycretin into Phase III trials for patients with obesity and who are overweight. Following a positive end-of-Phase II meeting, Novo ...

Kenzie Margiott Thu, June 12th 2025 at 7:51 AM Updated Thu, June 12th 2025 at 2:02 PM Nevada governor vetoes bill to expand paid leave benefits for workers (Photo by Ethan Miller/Getty Images) TOPICS: ...

K2 Medical Research, joined us, privately-owned clinical research facility now opened in our area. specialize in conducting multiphasic clinical trials that promote the development of innovative ...

In a Phase III clinical trial conducted by MIT spinout Lyndra Therapeutics, the researchers used the once-a-week pill to deliver a widely used medication for managing the symptoms of schizophrenia.

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains ...

Gilead stressed that this hold does not impact its clinical work on its other long-acting oral and injectable investigational HIV treatment combinations. Shares in the pharma were down around 2% ...